Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 19/20 | 0.63 |
| ▸ | ITGAV | P06756 | 18/20 | 0.63 |
| ▸ | ITGA2B | P08514 | 6/20 | 0.52 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.46 |
| ▸ | CAPN2 | P17655 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13231063 | 0.90 | ITGB3 (0.59) | ITGB3ITGAVITGA2BCAPN1CAPN2 | |
| SCHEMBL243035 | 0.85 | ITGB3 (0.61) | ITGB3ITGAVITGA2B | |
| SCHEMBL5755977 | 0.80 | ITGB3 (0.60) | ITGB3ITGAVITGA2B | |
| SCHEMBL8552051 | 0.79 | ITGB3 (0.62) | ITGB3ITGAVITGA2B | |
| SCHEMBL7404187 | 0.79 | ITGB3 (0.62) | ITGB3ITGAVITGA2B | |
| SCHEMBL7400967 | 0.78 | ITGB3 (0.59) | ITGB3ITGAVITGA2B | |
| SCHEMBL6111422 | 0.78 | ITGB3 (0.60) | ITGB3ITGAVITGA2B | |
| Iodide SCHEMBL7403601 | 0.78 | ITGB3 (0.60) | ITGB3ITGAVITGA2B | |
| SCHEMBL5027067 | 0.78 | ITGB3 (0.60) | ITGB3ITGAVITGA2B | |
| SCHEMBL8177327 | 0.78 | ITGB3 (0.60) | ITGB3ITGAVITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100297025-A1 | Novel compositions magnetic particles covered with gem-bisphosphonate derivatives | GUERBET. | 2010-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100297025-A1 | Novel compositions magnetic particles covered with gem-bisphosphonate derivatives | PHOSPHO1, SGMS2, PTEN | ITGB3 1890/4885ITGAV 2433/4885ITGA2B 1582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.